Document Type
Conference Proceeding
Publication Date
9-2023
Publication Title
Archives of Pathology & Laboratory Medicine
Abstract
Context: The prevalence of renal tumors arising from adult polycystic kidney disease (APKD) has been rarely reported in the pathology literature. We report our findings of various renal tumors in APKD nephrectomy specimens.
Design: We searched our database for APKD during the past 11 years and identified various primary malignant tumors within the kidneys of APKD.
Results: Forty-eight nephrectomies with APKD were evaluated. Ten malignant tumors were identified in the APKD kidneys, indicating a prevalence of 20.8% (10/48; Table). These included 4 clear cell (CC) renal cell carcinomas (RCCs) ranging from 1 mm to 6.7 cm, 3 papillary RCCs (2.5, 3.5, and 14 cm with lymph node metastasis), 1 acquired cystic disease (ACD)–associated RCC (4 mm), 1 clear cell papillary (CCP) renal cell tumor (RCT), and 1 urothelial adenocarcinoma. The urothelial adenocarcinoma was found near a tubulovillous adenoma in a collecting duct and stained positively for GATA3 and uroplakin-2 but was negative for PAX8 and CDX2. The tumor showed extensive invasion to perirenal fatty tissue and duodenum.
Conclusions: Our data show a prevalence of renal tumors at 20.8% in the APKD kidneys, higher than a previous report (12.4%, 11/89; Hajj et al, Urology, 2009). Renal tumors were mostly from damaged proximal tubular primary (clear cell or papillary RCC) but can be derived from distal tubular or urothelial primary as well
Volume
147
Issue
9
First Page
e64
Last Page
e65
Recommended Citation
Al-Othman Y, Elzieny M, Thorburn C, Schwartz JD, Daraiseh SI, Kanaan HD, Qu ZH, Zhang PL. Malignant tumors arising from adult polycystic kidney disease. Arch Pathol Lab Med. 2023 Sep;147(9):e64-e65. doi:10.5858/arpa.2023-0258-AB
DOI
10.5858/arpa.2023-0258-AB
Comments
College of American Pathologists 2023 Annual Meeting CAP23, October 7-10, 2023, Chicago, IL